文献速递肾小球疾病慢性肾脏病

基质金属蛋白酶-10被鉴定为足细胞损伤和蛋白尿的关键介质

Identification of matrix metalloproteinase-10 as a key mediator of podocyte injury and proteinuria.
PubMed 文献 · Kidney Int · 2021-06-24

该研究通过RNA测序发现基质金属蛋白酶-10(MMP-10)在肾小球损伤后显著上调,并在蛋白尿性慢性肾脏病患者足细胞中特异性升高,循环MMP-10水平与肾功能不全严重程度相关。转基因小鼠足细胞过表达MMP-10加重阿霉素诱导的蛋白尿和肾小球硬化,而体内敲低MMP-10则保护小鼠免受蛋白尿、恢复足细胞完整性并减少肾纤维化。机制上,MMP-10直接降解足细胞紧密连接蛋白ZO-1,提示ZO-1是MMP-10的新底物。

要点

  • MMP-10在损伤肾小球足细胞中特异性上调,循环水平与肾功能不全严重程度相关。
  • 足细胞过表达MMP-10加重蛋白尿和肾小球硬化,敲低则保护并减少纤维化。
  • MMP-10通过直接降解ZO-1蛋白导致足细胞损伤,不改变其mRNA水平。

核心结论

  • MMP-10诱导可通过降解ZO-1导致足细胞损伤,从而促进慢性肾脏病中的蛋白尿和肾小球硬化。

研究设计与样本

  • 研究对肾小球进行RNA测序基因表达谱分析,并在动物模型和蛋白尿性慢性肾脏病患者中验证。
  • 使用足细胞特异性MMP-10转基因小鼠和体内MMP-10敲低小鼠,结合阿霉素损伤模型。
  • 体外将纯化ZO-1与MMP-10孵育检测蛋白降解。

主要发现

  • RNA测序发现MMP-10是肾小球损伤后上调最显著的基因之一。
  • 在动物模型和蛋白尿性慢性肾脏病患者中,MMP-10在损伤肾小球足细胞中特异性上调。
  • 慢性肾脏病患者循环MMP-10水平升高,且与肾功能不全严重程度相关。
  • 足细胞特异性表达MMP-10的转基因小鼠在阿霉素损伤后蛋白尿加重,伴更严重足细胞病变和肾小球硬化病变。
  • 体内敲低MMP-10保护小鼠免受蛋白尿,恢复足细胞完整性并减少肾纤维化。

临床怎么用

  • MMP-10可作为足细胞损伤和蛋白尿性慢性肾脏病的潜在生物标志物进行监测。
  • 靶向MMP-10或其底物ZO-1降解通路可能成为减轻蛋白尿和肾小球硬化的治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Podocyte injury or dysfunction plays an essential role in causing proteinuria and glomerulosclerosis in chronic kidney diseases. To search for new players involved in podocyte injury, we performed gene expression profiling in the glomeruli by RNA sequencing. This unbiased approach led us to discover matrix metalloproteinase-10 (MMP-10), a secreted zinc-dependent endopeptidase, as one of the most upregulated genes after glomerular injury. In animal models and patients with proteinuric chronic kidney diseases, MMP-10 was upregulated specifically in the podocytes of injured glomeruli. Patients with chronic kidney diseases also had elevated circulating levels of MMP-10, which correlated with the severity of kidney insufficiency. In transgenic mice with podocyte-specific expression of MMP-10, proteinuria was aggravated after injury induced by Adriamycin. This was accompanied by more severe podocytopathy and glomerulosclerotic lesions. In contrast, knockdown of MMP-10 in vivo protected mice from proteinuria, restored podocyte integrity and reduced kidney fibrosis. Interestingly, MMP-10 reduced podocyte tight junctional protein zonula occludens-1 (ZO-1) but did not affect its mRNA level. Incubation of purified ZO-1 with MMP-10 directly resulted in its proteolytic degradation in vitro, suggesting ZO-1 as a novel substrate of MMP-10. Thus, our findings illustrate that induction of MMP-10 could lead to podocyte injury by degrading ZO-1, thereby promoting proteinuria and glomerulosclerosis in chronic kidney diseases.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Zuo Y, Wang C, Sun X, et al. Identification of matrix metalloproteinase-10 as a key mediator of podocyte injury and proteinuria. Kidney Int. 2021. PMID: 34175352. doi:10.1016/j.kint.2021.05.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。